BG103933A - 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate - Google Patents
5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleateInfo
- Publication number
- BG103933A BG103933A BG103933A BG10393399A BG103933A BG 103933 A BG103933 A BG 103933A BG 103933 A BG103933 A BG 103933A BG 10393399 A BG10393399 A BG 10393399A BG 103933 A BG103933 A BG 103933A
- Authority
- BG
- Bulgaria
- Prior art keywords
- ethyl
- methyl
- tetrazol
- tetrahydropyridine
- maleate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK78197 | 1997-07-01 | ||
| PCT/DK1998/000294 WO1999001448A1 (fr) | 1997-07-01 | 1998-07-01 | Maleate de 5-(2-ethyl-2h-tetrazole-5-yl)-1-methyle-1,2,3,6-tetrahydropyridine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103933A true BG103933A (en) | 2000-07-31 |
Family
ID=8097489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103933A BG103933A (en) | 1997-07-01 | 1999-11-30 | 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0994869A1 (fr) |
| JP (1) | JP2002507215A (fr) |
| KR (1) | KR20010014297A (fr) |
| CN (1) | CN1261361A (fr) |
| AR (1) | AR013096A1 (fr) |
| AU (1) | AU735751B2 (fr) |
| BG (1) | BG103933A (fr) |
| BR (1) | BR9810331A (fr) |
| CA (1) | CA2293324A1 (fr) |
| CO (1) | CO4940483A1 (fr) |
| EA (1) | EA200000081A1 (fr) |
| HU (1) | HUP0002876A2 (fr) |
| IL (1) | IL133093A0 (fr) |
| IS (1) | IS5278A (fr) |
| JO (1) | JO2031B1 (fr) |
| MA (1) | MA25138A1 (fr) |
| NO (1) | NO996580L (fr) |
| PE (1) | PE116099A1 (fr) |
| PL (1) | PL337184A1 (fr) |
| SK (1) | SK187399A3 (fr) |
| TN (1) | TNSN98120A1 (fr) |
| TR (1) | TR199903283T2 (fr) |
| UY (2) | UY25069A1 (fr) |
| WO (1) | WO1999001448A1 (fr) |
| ZA (1) | ZA985498B (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
| TR199800801T2 (xx) * | 1995-11-06 | 1998-08-21 | H. Lund-Beck A/S | Travmatik beyin yaralanmalar�n�n tedavisi. |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/es not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/xx unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/es not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/es unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/es not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/fr unknown
- 1998-07-01 EP EP98930655A patent/EP0994869A1/fr not_active Withdrawn
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/pt not_active Application Discontinuation
- 1998-07-01 CA CA002293324A patent/CA2293324A1/fr not_active Abandoned
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/xx unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/ja active Pending
- 1998-07-01 MA MA25155A patent/MA25138A1/fr unknown
- 1998-07-01 EA EA200000081A patent/EA200000081A1/ru unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 CN CN98806497A patent/CN1261361A/zh active Pending
- 1998-07-01 SK SK1873-99A patent/SK187399A3/sk unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/hu unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/ko not_active Application Discontinuation
- 1998-07-01 PL PL98337184A patent/PL337184A1/xx unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/fr not_active Application Discontinuation
- 1998-07-01 IL IL13309398A patent/IL133093A0/xx unknown
- 1998-09-10 UY UY25177A patent/UY25177A1/es not_active Application Discontinuation
-
1999
- 1999-11-30 IS IS5278A patent/IS5278A/is unknown
- 1999-11-30 BG BG103933A patent/BG103933A/xx unknown
- 1999-12-30 NO NO996580A patent/NO996580L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE116099A1 (es) | 1999-11-23 |
| JP2002507215A (ja) | 2002-03-05 |
| CO4940483A1 (es) | 2000-07-24 |
| CA2293324A1 (fr) | 1999-01-14 |
| IS5278A (is) | 1999-11-30 |
| AR013096A1 (es) | 2000-12-13 |
| SK187399A3 (en) | 2000-06-12 |
| NO996580D0 (no) | 1999-12-30 |
| HUP0002876A2 (hu) | 2001-06-28 |
| CN1261361A (zh) | 2000-07-26 |
| TR199903283T2 (xx) | 2000-06-21 |
| AU735751B2 (en) | 2001-07-12 |
| AU8102098A (en) | 1999-01-25 |
| NO996580L (no) | 1999-12-30 |
| JO2031B1 (en) | 1999-05-15 |
| BR9810331A (pt) | 2000-09-05 |
| MA25138A1 (fr) | 2001-04-02 |
| PL337184A1 (en) | 2000-08-14 |
| EP0994869A1 (fr) | 2000-04-26 |
| UY25069A1 (es) | 1998-12-21 |
| WO1999001448A1 (fr) | 1999-01-14 |
| UY25177A1 (es) | 2000-12-29 |
| EA200000081A1 (ru) | 2000-08-28 |
| ZA985498B (en) | 1999-01-20 |
| IL133093A0 (en) | 2001-03-19 |
| KR20010014297A (ko) | 2001-02-26 |
| TNSN98120A1 (fr) | 2005-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2000006085A3 (fr) | Composes et procedes | |
| DE69528823D1 (en) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
| MXPA04002982A (es) | Derivados de pirrolidinona. | |
| CA2297911A1 (fr) | 6-phenylphenanthridines substitues | |
| IL99912A0 (en) | Cyclosporins,their preparation and pharmaceutical compositions containing them | |
| EP2767291A3 (fr) | Traitement d'une glycogénose de type II | |
| PL361341A1 (en) | Novel pharmaceutical composition | |
| DE69929235D1 (de) | Spiro-indole als y5-rezeptor antagonisten | |
| HK1033582A1 (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
| EP1808177A3 (fr) | Procédés de traitement des troubles mitochondriaux | |
| DE60205234D1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten | |
| WO2001081347A3 (fr) | Principes actifs diazabicycliques pour le systeme nerveux central | |
| TR200000015T2 (tr) | Bileşikler ve metodlar | |
| HUT73807A (en) | 5-ht1-like indole derivatives and pharmaceutical compositions containing them | |
| CA2250569A1 (fr) | Nouvelles phenanthridines substituees en position 6 | |
| IL146448A0 (en) | Dr4 antibodies and uses thereof | |
| AU4310097A (en) | Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists | |
| WO1999045098A3 (fr) | Apport de proteines a des cellules eucaryotes au moyen de la yersinia recombinee | |
| BG105256A (en) | Muscarinic agonists and antagonists | |
| BG105761A (en) | Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | |
| CA2161533A1 (fr) | Derives de l'indole | |
| WO2001010408A3 (fr) | Composition pharmaceutique aqueuse a base de moxifloxacine ou de ses sels | |
| KR100292396B1 (fr) | ||
| WO2000040232A3 (fr) | Nouvelles compositions et trousses de bretylium, et leur utilisation dans la prevention et le traitement des pathologies cardio-vasculaires | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease |